You are here

  • Home
  • Archive
  • Volume 13, Issue 4
  • Use of oral contraceptives is not associated with increased risk of death in the UK; a net benefit in all-cause mortality was seen in ever users versus never users – RR 0.88, 95% CI 0.82 to 0.93

Article Text

Article menu
Download PDFPDF
Aetiology
Prospective cohort study
Use of oral contraceptives is not associated with increased risk of death in the UK; a net benefit in all-cause mortality was seen in ever users versus never users – RR 0.88, 95% CI 0.82 to 0.93
  1. Jane Clarke
  1. School of Medicine, University of Auckland, Auckland, New Zealand
  1. Correspondence to Jane Clarke
    Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand; j.clarke{at}auckland.ac.nz

https://doi.org/10.1136/ebn1084

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Hannaford PC, Iversen L, Macfarlane TV, et al. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study. BMJ 2010;340:c927.OpenUrlAbstract/FREE Full Text

    The combined oral contraceptive pill (OCP) was first used in 1956 in Puerto Rico and is frequently referred to as ‘the Pill’. It is a combination of oral oestrogen and a progestin (progestogen) taken for contraception by over 100 million women worldwide. The OCPs were perceived as a convenient, effective and reversible means of contraception. Ever since OCPs were first introduced, their relative safety has been the focus of much debate.1 Concerns are derived from the influences that these hormone-based therapies are used upon a …

    View Full Text

    Footnotes

    • Competing interests None.